ALK and lung cancer: Whilst a diagnosis of non‐small cell lung cancer (NSCLC) in pregnancy is rare, anaplastic lymphoma kinase (ALK)-rearranged NSCLCs accounts for 38% of NSCLC in women of childbearing age [5].